Johnson & Johnson Subsidiary LTL Management LLC Re-Files for Voluntary Chapter 11 to Equitably Resolve All Current and Future Talc Claims Pharmaceutical Investing
Merck Ranked No. 1 in the Pharmaceutical Industry Among Barron's 100 Most Sustainable U.S. Companies 2023 Life Science Investing
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Univar Solutions Inc. , Oak Street Health , Seagen Inc. , U.S. Xpress Enterprises, Inc. Life Science Investing
Lobe Sciences to Present at Sequire Cannabis & Psychedelics Conference April 5, 2023 Pharmaceutical Investing
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, April 26, 2023 Medical Device Investing
New Research: More Than Half of IBS Patients Surveyed Report Waiting More Than One Year Before Discussing IBS Symptoms With Their Healthcare Provider Pharmaceutical Investing
Seelos Therapeutics Doses the First Amyotrophic Lateral Sclerosis Patient with SLS-005 in an Expanded Access Program Psychedelics Investing
FDA Accepts Pfizer's Supplemental New Drug Applications for BRAFTOVI + MEKTOVI Life Science Investing
